Ovarian cancer. Malignant neoplasm of ovary
Conditions
Sponsors
Kian Gen Azma Company
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Confirmation of the patient's ovarian cancer by a gynecologist Diagnosis of disease as drug resistance Patient age 18 to 70 Absence of pregnancy. The Karnofsky performance score (KPS) of the patient is more than 50% (the patient is not disabled and does not need special assistance and care). The ability to understand and sign the consent form by the patient and one of these cases: the patient's spouse, parent or guardian. Proper functioning of liver, kidney and bone marrow Complying with all protocol steps including sample submission and returning to the clinical study site for subsequent visits Absence of autoimmune diseases or diseases of the immune system
Exclusion criteria
Exclusion criteria: Life-threatening acute infection Absence of any previous record that describes the doctor's treatment and orders were nor followed by patient. Using drugs that weaken the immune system Affected by any diseases that disturbs the immune system Having any previous record of organ transplantation Allergy to measles vaccine pregnancy Using other investigational treatments at the same time Being effected by other cancers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fever. Timepoint: Hourly in the first 24 hours and then daily up to 7 days. Method of measurement: Thermometer.;Examining changes in the patient's heart condition. Timepoint: Hourly after the start of treatment for up to 7 days. Method of measurement: Electrocardiogram.;Examining changes in the patient's breathing status. Timepoint: Hourly in the first 24 hours and then daily up to 7 days. Method of measurement: pulse oximeter.;Examining the amount of ca 125 cancer antigen in the blood. Timepoint: Weekly until 3 months after the end of treatment. Method of measurement: Blood test.;Examination of tumors of the abdominal cavity. Timepoint: Weekly until 3 months after the end of treatment. Method of measurement: Sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRuhollah Dorostkar
Bagheiat-allah University of Medical Sciences
Outcome results
None listed